CapVest to Acquire Majority Stake in STADA Arzneimittel AG from Bain Capital and Cinven

Bain Capital Private Equity Takes Majority Stake in InnovaCare Health

November 19, 2021

Healthcare Services

Bain Capital Private Equity has signed a definitive agreement to acquire a majority stake in InnovaCare Health, a regional leader in integrated and value-based healthcare services. The investment will support InnovaCare's national expansion and accelerate growth of its physician-led, value-based care model; Summit Partners will remain an equity holder and management will retain significant ownership.

CapVest Acquires Natra from Investindustrial

July 18, 2022

Food & Beverage

Funds managed by CapVest Partners LLP have signed an agreement to acquire Natra, a European producer and distributor of chocolate and cocoa products, from Investindustrial. The deal gives CapVest a platform in the chocolate category to accelerate international growth, support innovation and pursue strategic acquisitions.

CapVest Recapitalizes Curium via New Continuation Vehicle

November 20, 2025

Healthcare Services

Curium and CapVest Partners LLP announced the recapitalization of Curium via a new Continuation Vehicle, valuing Curium at approximately $7 billion. The transaction is expected to be completed in Q1 2026, subject to regulatory approvals, and CapVest will remain the controlling shareholder.

Vestar Capital Launches $1.2B Continuation Vehicle for Circana (Blackstone, HarbourVest lead)

April 25, 2024

Data & Analytics

Vestar Capital Partners closed a $1.2 billion single-asset continuation vehicle to provide liquidity and committed capital for its stake in Circana. Blackstone Strategic Partners and HarbourVest Partners acted as lead investors in the vehicle, which is intended to offer existing investors optional liquidity while supporting Circana's organic and inorganic growth initiatives.

Cinven Acquires Majority Stake in BioAgilytix; Cobepa Reinvests

December 20, 2021

Healthcare Services

International private equity firm Cinven has agreed to acquire a majority stake in BioAgilytix through a recapitalization, with current investor Cobepa remaining a significant minority investor. GHO Capital has realised its investment and will exit; the transaction will provide funding to support BioAgilytix’s international expansion, capacity and capability investments, and buy-and-build strategy in large-molecule bioanalytical services. BioAgilytix is headquartered in Durham, North Carolina and employs about 870 staff across the United States, Europe and Australia.

Adenia Partners Acquires Majority Stake in Parkville Pharmaceuticals

January 30, 2026

Healthcare Services

Adenia Partners has signed definitive agreements to acquire a majority stake in Parkville Pharmaceuticals, marking its first majority investment in Egypt. The deal is subject to customary closing conditions and regulatory approvals, and financial terms were not disclosed.